SubsidieMeestersAccessible MRI
The AMRI project by CHIPIRON aims to develop an affordable, compact MRI scanner using ultra-low magnetic fields to enhance accessibility and diagnostic capabilities in underserved regions.
Projectdetails
Introduction
The AMRI (Accessible MRI) project by CHIPIRON aims to develop and commercialize a breakthrough, compact, and affordable MRI scanner operating at an ultra-low magnetic field of around 10mT. This radical innovation eliminates the need for costly, massive superconducting magnets used in standard clinical MRIs. CHIPIRON's proprietary SQUID-based detection system provides ultra-high sensitivity to enable diagnostic-quality imaging at 100-1000x lower field strength.
Objectives
The goal is to make MRI, a vital, non-invasive diagnostic tool, accessible to a much wider population, especially in developing regions and rural areas where current MRI costs and infrastructure are prohibitive. The open design of the device also accommodates patients unable to use traditional MRIs due to contraindications.
Technical Development
Led by experienced technical experts, CHIPIRON has assembled proprietary IP and demonstrated core capabilities, reaching TRL 5 thus far. The company has raised €4.3M from investors and grants.
Funding Request
CHIPIRON is requesting a €2.5M EIC Transition grant which will be followed by a request for €15M EIC Accelerator investment to complete development through regulatory approvals and market launch over 2024-2027.
Impact of EIC Support
This long-term EIC support will help derisk technical milestones and provide necessary scale-up capital. It represents an ideal public-private funding mix tailored to the needs of deep tech medtech innovation.
Conclusion
The grant and investment will catalyze CHIPIRON's progress at a crucial juncture, enabling this breakthrough deployable MRI technology to benefit healthcare systems and patients worldwide.
Financiële details & Tijdlijn
Financiële details
| Subsidiebedrag | € 2.499.999 |
| Totale projectbegroting | € 2.499.999 |
Tijdlijn
| Startdatum | 1-12-2024 |
| Einddatum | 30-11-2026 |
| Subsidiejaar | 2024 |
Partners & Locaties
Projectpartners
- CHIPIRONpenvoerder
Land(en)
Vergelijkbare projecten binnen EIC Accelerator
| Project | Regeling | Bedrag | Jaar | Actie |
|---|---|---|---|---|
A new cardioprotective drug for acute treatment of myocardial infarctionResoTher aims to validate RTP-026, an immunomodulating therapy, to reduce heart damage and HF risk post-myocardial infarction through Phase II clinical studies. | EIC Accelerator | € 2.499.999 | 2024 | Details |
"The NIMBLE System: A novel non-invasive and non-ionizing medical device for the continous monitoring of patients with implanted cardiovascular stents"""NIMBLE Diagnostics is developing a microwave-based device for non-invasive stent monitoring, aiming to shift from reactive to proactive care and improve patient outcomes. | EIC Accelerator | € 2.306.500 | 2024 | Details |
Autonomous robotics and digital TWIN to improve water network performancesThe project develops a robotic inspection system for water utilities, enabling autonomous pipeline assessments to enhance water quality and sustainability through a subscription-based RaaS model. | EIC Accelerator | € 2.478.210 | 2024 | Details |
Toopi Regen: Unleash the power of urine to finally scale a real closed loop and regenerative farming systemToopi Organics aims to revolutionize agriculture by up-cycling human urine into sustainable biostimulants, reducing reliance on mineral fertilizers while enhancing soil health and farmer profitability. | EIC Accelerator | € 2.396.457 | 2024 | Details |
A new cardioprotective drug for acute treatment of myocardial infarction
ResoTher aims to validate RTP-026, an immunomodulating therapy, to reduce heart damage and HF risk post-myocardial infarction through Phase II clinical studies.
"The NIMBLE System: A novel non-invasive and non-ionizing medical device for the continous monitoring of patients with implanted cardiovascular stents"""
NIMBLE Diagnostics is developing a microwave-based device for non-invasive stent monitoring, aiming to shift from reactive to proactive care and improve patient outcomes.
Autonomous robotics and digital TWIN to improve water network performances
The project develops a robotic inspection system for water utilities, enabling autonomous pipeline assessments to enhance water quality and sustainability through a subscription-based RaaS model.
Toopi Regen: Unleash the power of urine to finally scale a real closed loop and regenerative farming system
Toopi Organics aims to revolutionize agriculture by up-cycling human urine into sustainable biostimulants, reducing reliance on mineral fertilizers while enhancing soil health and farmer profitability.
Vergelijkbare projecten uit andere regelingen
| Project | Regeling | Bedrag | Jaar | Actie |
|---|---|---|---|---|
MIRACLE the platform for virtual biopsies; introducing Metabolic MRI-as-a-Service for oncologic careMIRACLE aims to develop a non-invasive MRI add-on for virtual biopsies, enabling personalized cancer treatment decisions by providing structural and metabolic tumor information globally. | EIC Transition | € 2.495.127 | 2022 | Details |
Screening And Future Enhanced MRISAFE-MRI seeks to enhance breast cancer detection and MRI performance by implementing abbreviated screening for younger women and reducing contrast use through advanced imaging techniques. | ERC COG | € 2.984.796 | 2023 | Details |
Truly portable MRI for extremity and brain imaging anywhere & everywhereThe NextMRI project aims to develop portable low-field MRI systems for accessible point-of-care imaging, enhancing diagnostic capabilities and usability for underserved populations globally. | EIC Transition | € 2.494.415 | 2023 | Details |
MRI-scannerHet project onderzoekt de haalbaarheid van een compacte, goedkopere 3 Tesla MRI-scanner met supergeleidende magneten en stikstofkoeling, ter verbetering van gezondheidszorg en kostenverlaging. | MIT Haalbaarheid | € 20.000 | 2023 | Details |
MIRACLE the platform for virtual biopsies; introducing Metabolic MRI-as-a-Service for oncologic care
MIRACLE aims to develop a non-invasive MRI add-on for virtual biopsies, enabling personalized cancer treatment decisions by providing structural and metabolic tumor information globally.
Screening And Future Enhanced MRI
SAFE-MRI seeks to enhance breast cancer detection and MRI performance by implementing abbreviated screening for younger women and reducing contrast use through advanced imaging techniques.
Truly portable MRI for extremity and brain imaging anywhere & everywhere
The NextMRI project aims to develop portable low-field MRI systems for accessible point-of-care imaging, enhancing diagnostic capabilities and usability for underserved populations globally.
MRI-scanner
Het project onderzoekt de haalbaarheid van een compacte, goedkopere 3 Tesla MRI-scanner met supergeleidende magneten en stikstofkoeling, ter verbetering van gezondheidszorg en kostenverlaging.